ReviewAllergy, asthma & immunology research2026
Wheat Allergy: Clinical Phenotypes, Diagnostic Approaches, and Management Strategies.
Review in Allergy, asthma & immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Wheat triggers a broad spectrum of allergic diseases, with prevalence varying across regions. In adults, it is the leading cause of food-induced anaphylaxis, most often as wheat-dependent exercise-induced anaphylaxis (WDEIA), while occupational exposure causes baker's asthma. In children, wheat allergy manifests as immediate-type reactions, including anaphylaxis, and contributes to atopic dermatitis. Recently, wheat is known as one of key triggers of eosinophilic esophagitis across all age groups. Wheat proteins are classified into water/salt-soluble and -insoluble fractions, with distinct physiochemical profiles. Among insoluble proteins, ω-5 gliadin and high- and low-molecular weight glutenins are well recognized as major allergens in WDEIA. Conversely, both gluten proteins and water-salt soluble allergens, such as α-amylase inhibitors and lipid-transfer proteins, are key allergens in pediatric wheat allergy and baker's asthma. Accurate diagnosis requires component-resolved diagnostics (CRD), given the complex physicochemical properties of wheat proteins. However, conventional skin prick testing and some multiplex specific immunoglobulin E assays lack full CRD integration, likely underestimating true prevalence. Management primarily relies on avoidance, but strict elimination is difficult due to wheat's ubiquity. In WDEIA, cofactors such as exercise, alcohol, or nonsteroidal anti-inflammatory drugs commonly precipitate reactions, with provoking doses varying widely, necessitating individualized strategies. Oral immunotherapy has been attempted for pediatric wheat allergy but demonstrated lower efficacy than for other foods, underscoring the need for patient-tailored strategies. Baker's asthma management focuses on work-place control, personal respiratory protective equipment, and pharmacotherapy. Overall, improved CRD-based diagnostics and novel therapeutic approaches are needed to enhance care for this diverse spectrum of wheat-related allergic diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.